Infection and Infection Prevention in Patients Treated with Immunosuppressive Medications for Autoimmune Bullous Disorders

Julia S. Lehman, Dédée F. Murrell, Michael J. Camilleri, Amer N. Kalaaji

Research output: Contribution to journalReview articlepeer-review

20 Scopus citations

Abstract

Infection contributes to considerable morbidity and mortality in patients treated for autoimmune bullous disorders because of the impaired cutaneous barrier, alteration of the protective normal flora, and host immunosuppression (inherent and iatrogenic). Prevention of cutaneous impetiginization and infection starts with excellent wound care. In patients to be started on immunosuppressive medications, consideration should be given to vaccination status and possible need for pneumocystis pneumonia prevention. Patients should be educated on the signs and symptoms of early infection and the need to seek early medical intervention as needed.

Original languageEnglish (US)
Pages (from-to)591-598
Number of pages8
JournalDermatologic Clinics
Volume29
Issue number4
DOIs
StatePublished - Oct 1 2011

Keywords

  • Immunization
  • Immunobullous disease
  • Immunosuppressive medication
  • Infection
  • Vaccination
  • Wound healing

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Infection and Infection Prevention in Patients Treated with Immunosuppressive Medications for Autoimmune Bullous Disorders'. Together they form a unique fingerprint.

Cite this